30 Best CEOs of the Year 2020 30 Best CEOs of the Year 2020 | Page 13

platform for regenerative medicine,
along with drafting and passing
tort reform legislation for personal
responsibility in ice arenas. These
all required different skill sets and
disciplines which ranged from
science and biology to mechanical
engineering and politics.
What do you think is the
most memorable moment in
your career?
The improvement we made in those
patients’ lives is such a motivating
factor to commercialize this product
and offer a cure to individuals
suffering from lower back pain.
What other CEOs do you look
up to?
So far, I would have to say the human
trial results from using fibroblasts
to treat Degenerative Disc Disease.
Instead of looking up to operational
type CEOs, I find myself gravitating
to the more creative CEOs like
Steve Jobs, Jeff Bezos, Elon Musk,
and even Thomas Edison. These
CEOs possess the broad skill set that
I strive to develop. Each one defined
their generation through science,
technology and even politics.
If not a business leader/CEO,
what else you want to be?
I would probably be a marine
biologist or a geologist. I have
always been interested in science
and biology.
Give me one word that
describes you the best.
The one word that describes me the
best is ‘determined’.
SR
Pete O’Heeron: A Formidable Leader
Pete O’Heeron serves as the Chief Executive Officer of
Pete O’Heeron, CEO
SpinalCyte, LLC. With more than 20 years of medical technology
development experience, Mr. O’Heeron brings together the resources
necessary to commercialize unique technologies. His expertise covers a broad
range of disciplines, from business start-ups and biologics to medical devices
and patient-centered healthcare delivery. Prior to founding SpinalCyte, LLC,
Mr. O’Heeron founded and still serves as the CEO of an operational investment
group, Advanced Medical Technologies, LLC, which identifies early-stage
opportunities in the medical field with strong intellectual property potential.
Mr. O’Heeron’s previous experience includes the founding of NeoSurg
Technologies to develop a minimally invasive access system. As a result of
his efforts, NeoSurg Technologies was successful in launching the T2000
Minimally Invasive Access System, which reduced surgical equipment cost by
over 60 percent. Mr. O’Heeron completed the sale of NeoSurg Technologies
to CooperSurgical. Mr. O’Heeron was employed by Christus Health Care
Corporation in a variety of executive-level positions. He has provided strategic
advisory services to healthcare companies in the areas of biologics, surgical
instrumentation, and telemedicine.
Mr. O’Heeron earned a Master’s degree in Healthcare Administration from the
University of Houston. He completed Executive Management Certification in
Mergers and Acquisition from the University of Chicago and holds a Bachelor’s
Degree in Healthcare Administration with a minor in Business Administration
from Texas State University.
“Over the years, our research developed other uses for fibroblasts
and we’re currently developing a pipeline of clinical pathways
including diabetes, cancer, multiple sclerosis, Parkinson’s, and CTE.”